Combination of rituximab and mammalian target of rapamycin inhibitor everolimus (RAD001) in diffuse large B-cell lymphoma

Author: Xu Zi-Zhen   Wang Wen-Fang   Fu Wan-Bin   Wang Ai-Hua   Liu Zhi-Yin   Chen Li-Yun   Guo Pei   Li Jun-Min  

Publisher: Informa Healthcare

ISSN: 1042-8194

Source: Leukemia and Lymphoma, Vol.55, Iss.5, 2014-05, pp. : 1151-1157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content